Parameswaran Venugopal to Follow-Up Studies
This is a "connection" page, showing publications Parameswaran Venugopal has written about Follow-Up Studies.
Connection Strength
0.068
-
Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma. Leuk Lymphoma. 2011 Nov; 52(11):2097-104.
Score: 0.068